Skip to main content

Table 8 Summary of metabolic pathways for metabolites with significant changes in levels that associate with meprin β expression or deficiency and STZ-induced type 1 diabetes

From: Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy

Metabolite

Increase/decrease

Pathways

Group 1: changed levels in plasma associate with meprin expression or deficiency

 Taurocholic acid

Increases in WT

Bile acids/lipid metabolism

 LysoPC(16:1(9Z))

Decreases in WT

Lipid metabolism

 Indoxyl sulfate

Increases in WT

oxidative stress

Group 2: 8 changes in urine associate with meprin β expression or deficiency

 Taurocholic acida

Increase in WT

Bile acids (lipid metabolism)

 Ergothioneinea

Increase in WT

Gut/dietary source (histidine metabolism)

 Tyrosyl-Valinea

Increase in WT

Protein degradation (aromatic amino acid metabolism)

 Prenyl glucoside

Decrease in WT

Gut/dietary (fatty acyl glucoside)

 Homovanillic acid sulfate

increase in WT

Catecholamine metabolism

 Cortisol

Increase in WT

Steroid hormone synthesis/stress response

 Aromadendrin 3,7-diglucoside

Increase in WT

Gut/dietary (flavonoid)

 Phloretin 2′-O-glucuronidea

Increase in WT

Gut/dietary (flavonoid)

 3,5-Dihydroxy-3′,4′-dimethoxy-6,7- methylenedioxyflavone 3-glucuronide

Decrease in βKO

Gut/dietary

 Pantothenic acid

Decrease in βKO

Gut/dietary

 Indoxyl glucuronide

Decrease in βKO

Indole metabolism/gut microbiota

Group 3: changed levels in plasma associate with STZ-induced type 1 diabetes but independent of meprin β expression

 Hippuric acida

Increase at 4 and 8 weeks

Amino acid metabolism (phenylalanine polyphenol metabolism; uremia)

 Indole-3-carboxilic acid-O-sulphatea

Increase

Indole metabolism

 Fenoprofen glucuronidea

Increase

NSAID metabolite

Group 4: Changed levels in urine associate with STZ-induced type 1 diabetes but independent of meprin β expression

 Glycerophosphocholine

Decrease

Lipid metabolism (choline metabolism; glycerophosphocholine)

 Nicotinic acid

Decrease

Co-factor and vitamin (nicotinate and nicotinamide metabolism)

 1-Pyrroline-4-hydroxy-2-carboxylate

Decrease

Amino acid metabolism (arginine and proline metabolism)

 Indole-3-carboxylic acid

Decrease

Gut/Dietary (indole metabolism)

 a-L-threo-4-Hex-4-enopyranuronosyl-D-galacturonic acid

Decrease

Carbohydrate metabolism (glucuronic acid derivative)

  1. aVIP ≤ 2 but consistent significant increases at both 4 and 8 weeks post STZ